Effect of early immunomodulator use in moderate to severe pediatric Crohn disease-Reference-Cited by-同舟云学术

Effect of early immunomodulator use in moderate to severe pediatric Crohn disease

Published:2008-07 Issue:7 Volume:14 Page:949-954
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Punati Jaya,Markowitz James,Lerer Trudy,Hyams Jeffrey,Kugathasan Subra,Griffiths Anne,Otley Anthony,Rosh Joel,Pfefferkorn Marian,Mack David,Evans Jonathan,Bousvaros Athos,Moyer Susan M.,Wyllie Robert,Oliva-Hemker Maria,Mezoff Adam,LeLeiko Neal,Keljo David,Crandall Wallace

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference13 articles.

1. INFLAMMATORY BOWEL DISEASE IN PEDIATRIC AND ADOLESCENT PATIENTS

2. EPIDEMIOLOGY OF INFLAMMATORY BOWEL DISEASE

3. Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease

4. A controlled trial of azathioprine in Crohn's disease

5. Treatment of Crohn's Disease with 6-Mercaptopurine

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of early biologic therapy versus late/conventional therapy in children and adolescents with Crohn’s disease: A systematic review and meta-analysis;Saudi Journal of Gastroenterology;2023

2. Mercaptopurine Therapy;Pediatric Inflammatory Bowel Disease;2023

3. Prediction of thiopurine failure in pediatric Crohn’s disease: pediatric IBD Porto group of ESPGHAN;Pediatric Research;2022-08-25

4. Crohn’s Disease;Textbook of Pediatric Gastroenterology, Hepatology and Nutrition;2021-11-25

5. Proactive measurement of infliximab drug levels in children with Crohn’s disease;Annals of Gastroenterology;2021